Cancer patients and survivors share tips for coping with the uncertainty and isolation brought on by the coronavirus, and the coronavirus is impacting cancer clinical trials and treatment.

by Kate Yandell and Marci A. Landsmann

The spread of the coronavirus is having an impact on cancer care, and the Food and Drug Administration will require cigarette packaging and advertisements to come with new graphic warning labels.

by Kate Yandell

Experts offer information and cancer centers take precautions in light of the novel coronavirus, and the Food and Drug Administration approves an immunotherapy combination for liver cancer.

by Kate Yandell

A report shows that colorectal cancer incidence is decreasing in older adults while simultaneously rising in younger individuals, and the Food and Drug Administration approves a new treatment for multiple myeloma.

by Kate Yandell

Researchers find one possible explanation for the link between certain gut bacteria and colorectal cancer, and a study shows that the rate of appendix cancer is rising.

by Kate Yandell

A study shows that young cancer survivors have a higher death rate than their siblings in the decades following diagnosis, and a cancer survivor has a baby using immature eggs harvested prior to treatment and matured in the lab.

by Kate Yandell

A survey finds that outpatient palliative care clinics have become nearly ubiquitous in National Cancer Institute-designated cancer centers, and a group of oncology professionals calls for a cancer patient's bill of rights.

by Kate Yandell

A massive sequencing project reveals that mutations that drive cancer often occur years before the disease is diagnosed, and researchers report preliminary results from a trial for a new form of immunotherapy.

by Kate Yandell

A randomized trial shows that lung cancer screening reduces lung cancer deaths, and a study indicates that a single dose of psilocybin may have a lasting impact on cancer patients' anxiety and depression.

by Kate Yandell

A study shows that the rate of death following bone marrow transplant has decreased, and the U.S. Food and Drug Administration approves a new treatment for patients with a rare form of sarcoma.

by Kate Yandell